Career history of Robert Freisen
Former positions of Robert Freisen
| Companies | Position | Start | End |
|---|---|---|---|
| ABLYNX | Chief Tech/Sci/R&D Officer | 2018-02-28 | 2018-12-31 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 2015-12-31 | 2017-12-31 |
| Janssen Biotherapeutics | Corporate Officer/Principal | 2007-12-31 | 2013-12-31 |
| MORPHOSYS AG | Corporate Officer/Principal | - | - |
Training of Robert Freisen
| University of Utrecht | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Statistics
International
| Belgium | 3 |
| Netherlands | 3 |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| MORPHOSYS AG | Health Technology |
| Private companies | 2 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
| Janssen Biotherapeutics |
- Stock Market
- Insiders
- Robert Freisen
- Experience
